Background: Several risk factors for the recurrence of stage II colon cancer have been proposed; however, they remain unconfirmed. Moreover, whether circulating tumor cells in the peripheral blood are associated with recurrence is also unclear. Here, we identified these risk factors by post-hoc analysis of a prospective clinical trial assessing the efficacy of adjuvant chemotherapy for stage II colon cancer in patients with potential risk factors for recurrence.

No abstract